Literature DB >> 23460014

Management of extrapulmonary nontuberculous mycobacterial infections.

Shannon Kasperbauer1, Gwen Huitt.   

Abstract

Nontuberculous mycobacteria represent a vast group of environmental organisms that have the potential to cause disease in humans. Unlike tuberculosis, these organisms are not known to be transmitted from human to human. The most common clinical presentation is pulmonary disease. Approximately 10% of infections manifest as extrapulmonary disease. The portals of entry are the respiratory tract, gastrointestinal tract, or direct inoculation via trauma or an invasive procedure. Like tuberculosis, the nontuberculous mycobacteria have the potential to infect any organ system given the opportunity in an immunocompromised host. The spectrum of disease is extensive ranging from self-limited furunculosis to life-threatening disseminated infection. Common extrapulmonary manifestations include lymphadenitis, disseminated disease, skin, soft tissue, and bone infection. Less common manifestations include keratitis, catheter-related bloodstream infections, septic arthritis, central nervous system infection, and peritonitis. The incidence of extrapulmonary infections is unknown. Outbreaks have been reported due to inadequate disinfection of surgical equipment or contamination of injected solutions or medications. A high index of suspicion is required when patients present with subacute or chronic complaints of extrapulmonary infection. This review addresses the management of the common extrapulmonary nontuberculous infections. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23460014     DOI: 10.1055/s-0033-1333576

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  6 in total

1.  Outbreaks due to Mycobacterium abscessus subsp. bolletii in southern Brazil: persistence of a single clone from 2007 to 2011.

Authors:  Luciana de S Nunes; Ludmila F Baethgen; Marta O Ribeiro; Cássia M Cardoso; Fernanda de Paris; Simone M M De David; Marlei G da Silva; Rafael S Duarte; Afonso L Barth
Journal:  J Med Microbiol       Date:  2014-07-18       Impact factor: 2.472

Review 2.  Highlight on advances in nontuberculous mycobacterial disease in North America.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Mary Beth Allen; Golnaz Ebrahimi; Joseph O Falkinham
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

3.  Detection of Mycobacteria by Culture and DNA-Based Methods in Animal-Derived Food Products Purchased at Spanish Supermarkets.

Authors:  Iker A Sevilla; Elena Molina; Maitane Tello; Natalia Elguezabal; Ramón A Juste; Joseba M Garrido
Journal:  Front Microbiol       Date:  2017-06-09       Impact factor: 5.640

4.  Invasive Nontuberculous Mycobacterial Infections among Cardiothoracic Surgical Patients Exposed to Heater-Cooler Devices1.

Authors:  Meghan M Lyman; Cheri Grigg; Cara Bicking Kinsey; M Shannon Keckler; Heather Moulton-Meissner; Emily Cooper; Minn M Soe; Judith Noble-Wang; Allison Longenberger; Shane R Walker; Jeffrey R Miller; Joseph F Perz; Kiran M Perkins
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

5.  Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.

Authors:  Andenmatten Simon; Opota Onya; Jesica Mazza-Stalder; Laurent Nicod; Greub Gilbert; Jaton Katia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-16       Impact factor: 3.267

6.  Mycobacterium iranicum septic arthritis and tenosynovitis.

Authors:  Eugene M Tan; Aaron J Tande; Douglas R Osmon; John W Wilson
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.